Cardiovascular Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic & Monitoring (ECG, Holter, Mobile Cardiac Telemetry), Surgical Devices (Pacemakers, Stents)), By Region, And Segment Forecasts, 2025 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Cardiovascular Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
    • 3.3.1.1. Increasing prevalence of cardiovascular diseases
    • 3.3.1.2. Technological advancements
    • 3.3.1.3. Aging population
  • 3.3.2. Market restraint analysis
    • 3.3.2.1. Regulatory challenges
    • 3.3.2.2. High cost of development
• 3.4. Cardiovascular Devices Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape
  • 3.4.3. Pipeline Analysis

Chapter 4. Cardiovascular Devices: Product Estimates & Trend Analysis

• 4.1. Cardiovascular Devices Market: Product Key Takeaways
• 4.2. Cardiovascular Devices Market: Product Movement & Market Share Analysis, 2024 & 2033
• 4.3. Diagnostic and Monitoring Devices
  • 4.3.1. Diagnostic and monitoring devices estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.3.1.1. ECG
      • 4.3.1.1.1. ECG market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.3.1.2. Implantable Cardiac Monitors
      • 4.3.1.2.1. Implantable cardiac monitors market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.3.1.3. Holter Monitors
      • 4.3.1.3.1. Holter monitors market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.3.1.4. Mobile Cardiac Telemetry
      • 4.3.1.4.1. Mobile cardiac telemetry market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.3.1.5. MRI
      • 4.3.1.5.1. MRI estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.3.1.6. Cardiovascular Ultrasound
      • 4.3.1.6.1. Cardiovascular ultrasound market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.3.1.6.2. 2D
        • 4.3.1.6.2.1. 2D market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.3.1.6.3. 3D/4D
        • 4.3.1.6.3.1. 3D/4D market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.3.1.6.4. Doppler
        • 4.3.1.6.4.1. Doppler market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.3.1.7. Cardiac Diagnostic Catheters
      • 4.3.1.7.1. Cardiac diagnostic catheters market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.3.1.8. PET Scanner
      • 4.3.1.8.1. PET scanner market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.4. Surgical Devices
  • 4.4.1. Surgical devices market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.1.1. Cardiac Resynchronization Therapy (CRT)
      • 4.4.1.1.1. Cardiac resynchronization therapy (CRT) market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.1.1.2. CRT-Defibrillator
        • 4.4.1.1.2.1. CRT-defibrillator market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.1.1.3. CRT-Pacemaker
        • 4.4.1.1.3.1. CRT-pacemaker market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.1.2. Implantable Cardioverter Defibrillators (ICDs)
      • 4.4.1.2.1. Implantable cardioverter defibrillators (ICDs) market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.1.2.2. Single Chamber ICDs
        • 4.4.1.2.2.1. Single chamber ICDs market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.1.2.3. Dual Chamber ICDs
        • 4.4.1.2.3.1. Dual chamber ICDs market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.1.3. Pacemakers
      • 4.4.1.3.1. Pacemakers market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.1.3.2. Conventional Pacemakers
        • 4.4.1.3.2.1. Conventional pacemakers market estimates and forecasts, 2021 to 2033 (USD Million)
      • 4.4.1.3.3. Leadless Pacemakers
        • 4.4.1.3.3.1. Leadless pacemakers market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.1.4. Coronary Stents
      • 4.4.1.4.1. Coronary stents market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.1.5. Catheters
      • 4.4.1.5.1. Catheters market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.1.6. Guidewires
      • 4.4.1.6.1. Guidewires market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.1.7. Cannula
      • 4.4.1.7.1. Cannula market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.1.8. Valves
      • 4.4.1.8.1. Valves market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.4.1.9. Occlusion devices
      • 4.4.1.9.1. Occlusion devices market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Cardiovascular Devices Market: Regional Estimates & Trend Analysis by Country and Product

• 5.1. Regional Dashboard
• 5.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 5.3. North America
  • 5.3.1. U.S.
    • 5.3.1.1. Key country dynamics
    • 5.3.1.2. Regulatory framework/ reimbursement structure
    • 5.3.1.3. Competitive scenario
    • 5.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.3.2. Canada
    • 5.3.2.1. Key country dynamics
    • 5.3.2.2. Regulatory framework/ reimbursement structure
    • 5.3.2.3. Competitive scenario
    • 5.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
• 5.4. Europe
  • 5.4.1. UK
    • 5.4.1.1. Key country dynamics
    • 5.4.1.2. Regulatory framework/ reimbursement structure
    • 5.4.1.3. Competitive scenario
    • 5.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.2. Germany
    • 5.4.2.1. Key country dynamics
    • 5.4.2.2. Regulatory framework/ reimbursement structure
    • 5.4.2.3. Competitive scenario
    • 5.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.3. France
    • 5.4.3.1. Key country dynamics
    • 5.4.3.2. Regulatory framework/ reimbursement structure
    • 5.4.3.3. Competitive scenario
    • 5.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.4. Italy
    • 5.4.4.1. Key country dynamics
    • 5.4.4.2. Regulatory framework/ reimbursement structure
    • 5.4.4.3. Competitive scenario
    • 5.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.5. Spain
    • 5.4.5.1. Key country dynamics
    • 5.4.5.2. Regulatory framework/ reimbursement structure
    • 5.4.5.3. Competitive scenario
    • 5.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.6. Norway
    • 5.4.6.1. Key country dynamics
    • 5.4.6.2. Regulatory framework/ reimbursement structure
    • 5.4.6.3. Competitive scenario
    • 5.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.7. Sweden
    • 5.4.7.1. Key country dynamics
    • 5.4.7.2. Regulatory framework/ reimbursement structure
    • 5.4.7.3. Competitive scenario
    • 5.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.8. Denmark
    • 5.4.8.1. Key country dynamics
    • 5.4.8.2. Regulatory framework/ reimbursement structure
    • 5.4.8.3. Competitive scenario
    • 5.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. Asia Pacific
  • 5.5.1. Japan
    • 5.5.1.1. Key country dynamics
    • 5.5.1.2. Regulatory framework/ reimbursement structure
    • 5.5.1.3. Competitive scenario
    • 5.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.2. China
    • 5.5.2.1. Key country dynamics
    • 5.5.2.2. Regulatory framework/ reimbursement structure
    • 5.5.2.3. Competitive scenario
    • 5.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.3. India
    • 5.5.3.1. Key country dynamics
    • 5.5.3.2. Regulatory framework/ reimbursement structure
    • 5.5.3.3. Competitive scenario
    • 5.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.4. Australia
    • 5.5.4.1. Key country dynamics
    • 5.5.4.2. Regulatory framework/ reimbursement structure
    • 5.5.4.3. Competitive scenario
    • 5.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.5. South Korea
    • 5.5.5.1. Key country dynamics
    • 5.5.5.2. Regulatory framework/ reimbursement structure
    • 5.5.5.3. Competitive scenario
    • 5.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5.6. Thailand
    • 5.5.6.1. Key country dynamics
    • 5.5.6.2. Regulatory framework/ reimbursement structure
    • 5.5.6.3. Competitive scenario
    • 5.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
• 5.6. Latin America
  • 5.6.1. Brazil
    • 5.6.1.1. Key country dynamics
    • 5.6.1.2. Regulatory framework/ reimbursement structure
    • 5.6.1.3. Competitive scenario
    • 5.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6.2. Argentina
    • 5.6.2.1. Key country dynamics
    • 5.6.2.2. Regulatory framework/ reimbursement structure
    • 5.6.2.3. Competitive scenario
    • 5.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6.3. Mexico
    • 5.6.3.1. Key country dynamics
    • 5.6.3.2. Regulatory framework/ reimbursement structure
    • 5.6.3.3. Competitive scenario
    • 5.6.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
• 5.7. MEA
  • 5.7.1. South Africa
    • 5.7.1.1. Key country dynamics
    • 5.7.1.2. Regulatory framework/ reimbursement structure
    • 5.7.1.3. Competitive scenario
    • 5.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7.2. Saudi Arabia
    • 5.7.2.1. Key country dynamics
    • 5.7.2.2. Regulatory framework/ reimbursement structure
    • 5.7.2.3. Competitive scenario
    • 5.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7.3. UAE
    • 5.7.3.1. Key country dynamics
    • 5.7.3.2. Regulatory framework/ reimbursement structure
    • 5.7.3.3. Competitive scenario
    • 5.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7.4. Kuwait
    • 5.7.4.1. Key country dynamics
    • 5.7.4.2. Regulatory framework/ reimbursement structure
    • 5.7.4.3. Competitive scenario
    • 5.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Company/Competition Categorization
• 6.2. Vendor Landscape
  • 6.2.1. List of key distributors and channel partners
  • 6.2.2. Key customers
  • 6.2.3. Key company market share analysis, 2024
• 6.3. Market Participant Categorization
  • 6.3.1. Abbott
    • 6.3.1.1. Company overview
    • 6.3.1.2. Financial performance
    • 6.3.1.3. Product benchmarking
    • 6.3.1.4. Strategic initiatives
  • 6.3.2. GE HealthCare
    • 6.3.2.1. Company overview
    • 6.3.2.2. Financial performance
    • 6.3.2.3. Product benchmarking
    • 6.3.2.4. Strategic initiatives
  • 6.3.3. Edwards Lifesciences Corporation
    • 6.3.3.1. Company overview
    • 6.3.3.2. Financial performance
    • 6.3.3.3. Product benchmarking
    • 6.3.3.4. Strategic initiatives
  • 6.3.4. W. L. Gore & Associates, Inc.
    • 6.3.4.1. Company overview
    • 6.3.4.2. Financial performance
    • 6.3.4.3. Product benchmarking
    • 6.3.4.4. Strategic initiatives
  • 6.3.5. Siemens Healthcare GmbH
    • 6.3.5.1. Company overview
    • 6.3.5.2. Financial performance
    • 6.3.5.3. Product benchmarking
    • 6.3.5.4. Strategic initiatives
  • 6.3.6. BIOTRONIK SE & Co. KG
    • 6.3.6.1. Company overview
    • 6.3.6.2. Financial performance
    • 6.3.6.3. Product benchmarking
    • 6.3.6.4. Strategic initiatives
  • 6.3.7. Canon Medical Systems Asia Pte. Ltd.
    • 6.3.7.1. Company overview
    • 6.3.7.2. Financial performance
    • 6.3.7.3. Product benchmarking
    • 6.3.7.4. Strategic initiatives
  • 6.3.8. B. Braun SE
    • 6.3.8.1. Company overview
    • 6.3.8.2. Financial performance
    • 6.3.8.3. Product benchmarking
    • 6.3.8.4. Strategic initiatives
  • 6.3.9. LivaNova PLC
    • 6.3.9.1. Company overview
    • 6.3.9.2. Financial performance
    • 6.3.9.3. Product benchmarking
    • 6.3.9.4. Strategic initiatives
  • 6.3.10. Cardinal Health
    • 6.3.10.1. Company overview
    • 6.3.10.2. Financial performance
    • 6.3.10.3. Product benchmarking
    • 6.3.10.4. Strategic initiatives
  • 6.3.11. Medtronic
    • 6.3.11.1. Company overview
    • 6.3.11.2. Financial performance
    • 6.3.11.3. Product benchmarking
    • 6.3.11.4. Strategic initiatives
  • 6.3.12. Boston Scientific Corporation
    • 6.3.12.1. Company overview
    • 6.3.12.2. Financial performance
    • 6.3.12.3. Product benchmarking
    • 6.3.12.4. Strategic initiatives

List of Tables

• Table 1 List of abbreviation
• Table 2 North America cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 3 North America cardiovascular devices market, by region, 2021 - 2033 (USD Million)
• Table 4 U.S. cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 5 Canada cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 6 Mexico cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 7 Europe cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 8 Europe cardiovascular devices market, by region, 2021 - 2033 (USD Million)
• Table 9 Germany cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 10 UK cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 11 France cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 12 Italy cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 13 Spain cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 14 Sweden cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 15 Norway cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 16 Denmark cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 17 Asia Pacific cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 18 Asia Pacific cardiovascular devices market, by region, 2021 - 2033 (USD Million)
• Table 19 China cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 20 Japan cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 21 India cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 22 Australia cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 23 Thailand cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 24 South Korea cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 25 Latin America cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 26 Latin America cardiovascular devices market, by region, 2021 - 2033 (USD Million)
• Table 27 Brazil cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 28 Argentina cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 29 Middle East and Africa cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 30 Middle East and Africa cardiovascular devices market, by region, 2021 - 2033 (USD Million)
• Table 31 South Africa cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 32 Saudi Arabia cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 33 UAE cardiovascular devices market, by product, 2021 - 2033 (USD Million)
• Table 34 Kuwait cardiovascular devices market, by product, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Cardiovascular devices market: Market outlook
• Fig. 9 Cardiovascular devices market: Competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 Cardiovascular devices market driver impact
• Fig. 15 Cardiovascular devices market restraint impact
• Fig. 16 Cardiovascular devices market strategic initiatives analysis
• Fig. 17 Cardiovascular devices market: Product movement analysis
• Fig. 18 Cardiovascular devices market: Product outlook and key takeaways
• Fig. 19 Diagnostic and monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 20 ECG market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 21 Implantable cardiac monitors market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 22 Holter monitors market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 23 Mobile cardiac telemetry market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 24 MRI market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 25 Cardiovascular ultrasound market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 26 2D market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 27 3D/4D market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 28 Doppler market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 29 Cardiac diagnostic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 30 Pet scan market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 31 MRI market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 32 Cardiac CT market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 33 Doppler fetal monitors market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 34 PET scanner market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 35 Surgical devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 36 Cardiac resynchronization therapy (CRT) market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 37 CRT-defibrillator market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 38 CRT-pacemaker market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 39 Implantable cardioverter defibrillators (ICDs) market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 40 Single Chamber ICDs market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 41 Dual Chamber ICDs market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 42 Pacemakers market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 43 Conventional pacemakers market estimates and forecasts, 2021 - 2033 (USD Million
• Fig. 44 Leadless pacemaker market estimates and forecasts, 2021 - 2033 (USD Million
• Fig. 45 Coronary stents market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 46 Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 47 Cannula market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 48 Valves market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 49 Occlusion devices market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 50 Global cardiovascular devices market: Regional movement analysis
• Fig. 51 Global cardiovascular devices market: Regional outlook and key takeaways
• Fig. 52 North America market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 53 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 54 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 55 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 56 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 57 UK market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 58 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 59 France market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 60 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 61 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 62 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 63 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 64 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 65 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 66 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 67 China market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 68 India market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 69 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 70 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 71 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 72 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 73 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 74 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 75 Middle East and Africa. market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 76 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 77 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 78 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 79 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 80 Market share of key market players cardiovascular devices market